Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Turnover | 9.32%24.96M | 33.16%55.26M | 39.81%22.83M | 107.85%41.5M | --16.33M | -49.81%19.97M | --39.78M |
| Operating income | 9.32%24.96M | 33.16%55.26M | 39.81%22.83M | 107.85%41.5M | 16.33M | -49.81%19.97M | 39.78M |
| Cost of sales | -82.04%-12.12M | -71.97%-20.15M | -21.19%-6.66M | -38.33%-11.72M | ---5.49M | 11.80%-8.47M | ---9.61M |
| Operating expenses | -82.04%-12.12M | -71.97%-20.15M | -21.19%-6.66M | -38.33%-11.72M | -5.49M | 11.80%-8.47M | -9.61M |
| Gross profit | -20.62%12.84M | 17.88%35.11M | 49.26%16.17M | 159.10%29.78M | 10.84M | -61.91%11.49M | 30.18M |
| Administrative expenses | -25.38%-6.88M | -69.95%-17.26M | -48.12%-5.49M | -59.13%-10.16M | ---3.7M | -35.06%-6.38M | ---4.73M |
| Research and development expenses | -120.00%-616K | -514.16%-694K | ---280K | ---113K | ---- | ---- | ---- |
| Impairment and provision | -1,189.76%-1.64M | 141.84%551K | 92.01%-127K | 4.57%-1.32M | ---1.59M | 34.94%-1.38M | ---2.12M |
| -Other impairment is provision | -1,189.76%-1.64M | 141.84%551K | 92.01%-127K | 4.57%-1.32M | ---1.59M | 34.94%-1.38M | ---2.12M |
| Special items of operating profit | 1,188.00%322K | 2,517.43%5.83M | -92.11%25K | -159.65%-241K | --317K | -26.28%404K | --548K |
| Operating profit | -60.90%4.03M | 31.05%23.53M | 75.85%10.31M | 334.17%17.95M | 5.86M | -82.68%4.14M | 23.88M |
| Financing income | ---- | ---- | ---- | ---- | --33K | -3.00%97K | --100K |
| Financing cost | -53.69%-750K | -453.42%-1.21M | -243.66%-488K | 22.06%-219K | ---142K | -10.63%-281K | ---254K |
| Earning before tax | -66.60%3.28M | 25.84%22.32M | 70.70%9.82M | 348.85%17.73M | 5.75M | -83.35%3.95M | 23.72M |
| Tax | 43.78%-1.39M | -34.35%-6.02M | -68.64%-2.47M | -331.18%-4.48M | ---1.47M | 82.64%-1.04M | ---5.99M |
| After-tax profit from continuing operations | -74.29%1.89M | 22.96%16.3M | 71.41%7.34M | 355.15%13.25M | 4.28M | -83.58%2.91M | 17.74M |
| Earning after tax | -74.29%1.89M | 22.96%16.3M | 71.41%7.34M | 355.15%13.25M | 4.28M | -83.58%2.91M | 17.74M |
| Minority profit | --538K | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -81.62%1.35M | 22.96%16.3M | 71.41%7.34M | 355.15%13.25M | 4.28M | -83.58%2.91M | 17.74M |
| Basic earnings per share | -87.10%0.04 | -4.69%0.61 | 47.62%0.31 | 326.67%0.64 | 0.21 | -83.15%0.15 | 0.89 |
| Diluted earnings per share | -87.10%0.04 | -4.69%0.61 | 47.62%0.31 | 326.67%0.64 | 0.21 | -83.15%0.15 | 0.89 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.